BFC Planning’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.7K Hold
145
– – ﹤0.01% 2461
2026
Q2
$8.3K Buy
145
+3
+2% +$164 ﹤0.01% 2461
2026
Q1
$8.02K Buy
142
+136
+2,267% +$7.93K ﹤0.01% 2135
2025
Q4
$357 Hold
6
– – ﹤0.01% 2980
2025
Q3
$325 Hold
6
– – ﹤0.01% 2789
2025
Q2
$330 Buy
+6
New +$353 ﹤0.01% 2579

Other funds holding BMRN

BFC Planning's BMRN Position: Q3 2026 in Review

BFC Planning held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 145 shares worth $8.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

BFC Planning first reported a position in BMRN in Q2 2025 and has held it in 6 quarters since. 443 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • BFC Planning held 145 shares of BioMarin Pharmaceuticals worth $8.7K as of Q3 2026.
  • BFC Planning left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2461 holding.
  • BFC Planning first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 443 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.